Are too many Phase III cancer clinical trials set up to fail?

New research finds four out of five cancer therapies tested in Phase III trials do not achieve clinically-meaningful benefit in prolonging survival, and is the first study to quantify the number of false-positive, false-negative, and true-negative trial results.

Quelle: Sciencedaily